2014
Colorectal cancer screening: 20 years of development and recent progress
ZAVORAL, Miroslav; Stepan SUCHANEK; Ondřej MÁJEK; Premysl FRIC; Petra MINARIKOVA et al.Základní údaje
Originální název
Colorectal cancer screening: 20 years of development and recent progress
Autoři
ZAVORAL, Miroslav; Stepan SUCHANEK; Ondřej MÁJEK ORCID; Premysl FRIC; Petra MINARIKOVA; Marek MINARIK; Bohumil SEIFERT a Ladislav DUŠEK
Vydání
World Journal of Gastroenterology, Beijing, China, Baishideng, 2014, 1007-9327
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.369
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/14:00080133
Organizační jednotka
Lékařská fakulta
UT WoS
000334439200008
EID Scopus
2-s2.0-84898403521
Klíčová slova anglicky
Colorectal cancer; Population-based screening program; Colonoscopy; Fecal occult blood test
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 12. 6. 2014 17:22, Soňa Böhmová
Anotace
V originále
Colorectal cancer (CRC) is the second most common cancer in Europe and its incidence is steadily increasing. This trend could be reversed through timely secondary prevention (screening). In the last twenty years, CRC screening programs across Europe have experienced considerable improvements (fecal occult blood testing; transition from opportunistic to population based program settings). The Czech Republic is a typical example of a country with a long history of nationwide CRC screening programs in the face of very high CRC incidence and mortality rates. Each year, approximately 8000 people are diagnosed with CRC and some 4000 die from this malignancy. Twenty years ago, the first pilot studies on CRC screening led to the introduction of the opportunistic Czech National Colorectal Cancer Screening Program in 2000. Originally, this program was based on the guaiac fecal occult blood test (FOBT) offered by general practitioners, followed by colonoscopy in cases of FOBT positivity. The program has continuously evolved, namely with the implementation of immunochemical FOBTs and screening colonoscopy, as well as the involvement of gynecologists. Since the establishment of the Czech CRC Screening Registry in 2006, 2405850 FOBTs have been performed and 104565 preventive colonoscopies recorded within the screening program. The overall program expanded to cover 25.0% of the target population by 2011. However, stagnation in the annual number of performed FOBTs lately has led to switching to the option of a population-based program with personal invitation, which is currently being prepared.
Návaznosti
| NT13673, projekt VaV |
|